PROFOUND MEDICAL CORP. (PROF) Current Ratio
- Current ratio · latest quarter: Value 6.46×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 6.46× | Current assets / current liabilities. $58.86M ÷ $9.11M ≈ 6.46× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 58.86M USD | Assets, Current |
| Current obligations | 9.11M USD | Liabilities, Current |
| Cash and equivalents | 38.27M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory | 10.46M USD | Inventory, Net |
| Payables | 955.00K USD | Accounts Payable, Current |
| Borrowing debt due within one year | 4.51M USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $58.86M | $9.11M | $38.27M | (m) | (m) | $10.46M | $955.00K | $4.51M | 6.46× |
| 2026-03-31 | $69.53M | $10.61M | $50.30M | (m) | (m) | $9.00M | $2.14M | $4.50M | 6.56× |
| 2025-12-31 | $76.09M | $6.08M | $59.72M | (m) | (m) | $8.24M | $1.56M | (m) | 12.52× |
| 2025-09-30 | $41.52M | $9.94M | $24.83M | (m) | (m) | $8.34M | $717.00K | $4.48M | 4.18× |
| 2025-06-30 | $48.81M | $5.72M | $35.20M | (m) | (m) | $8.35M | $949.00K | (m) | 8.53× |
| 2025-03-31 | $59.91M | $5.29M | $46.43M | (m) | (m) | $6.79M | $1.05M | (m) | 11.31× |
| 2024-12-31 | $69.06M | $6.57M | $54.91M | (m) | (m) | $5.80M | $1.32M | $1.74M | 10.52× |
| 2023-12-31 | $41.90M | $6.37M | $26.21M | (m) | (m) | $6.99M | $865.00K | $2.10M | 6.58× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |